AI assistant
Sending…
DEXCOM INC — Director's Dealing 2020
Mar 11, 2020
30198_dirs_2020-03-10_43827a7a-dc9e-47c0-84d3-1908e9e2c427.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-03-06
Reporting Person: Selvaraj Shelly Ramasamy (SVP Information Technology)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 25351 | Direct |
Footnotes
F1: Included in this number are 21,726 unvested restricted stock units, 8,269 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,852 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1605 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17